title: Oxidative stress and obstructive sleep apnoea syndrome.
abstract: BACKGROUND
  Even though oxidative stress has been proposed as an underlying mechanism for the symptoms in patients with obstructive sleep apnoea syndrome (OSAS), little information is available on the effects of anti-oxidant treatment on their improvement.
  
  
  OBJECTIVE
  To observe the effects of anti-oxidant treatment on polysomnographic parameters and oxidative stress markers in OSAS patients.
  
  
  METHODS
  Polysomnography (PSG) was performed on 20 male patients. They were administered continuous positive airway pressure (CPAP) therapy for two nights followed by oral intake of vitamin C (100 mg BD) [DOSAGE ERROR CORRECTED] and vitamin E (400 IU BD) for 45 days and a repeat PSG was done. Ten healthy normal subjects underwent the same protocol excepting the CPAP therapy.
  
  
  RESULTS
  In OSAS patients, plasma lipid peroxidation increased significantly and whole blood reduced glutathione decreased significantly. The CPAP therapy as well as anti-oxidant treatment reduced the lipid peroxidation and restored the reduced glutathione concentrations. After anti-oxidant intake, OSAS patients slept better with decrease in Epworth sleepiness score and the number of apnoeic episodes. They spent more time in stages 3 and 4 of sleep. The optimum pressure of CPAP device was significantly lowered also.
  
  
  CONCLUSIONS
  Oxidative stress contributes to sleep behaviour in OSAS patients, and anti-oxidant intake improves the quality of sleep in them.
authors.affiliation: Department of Physiology, V P Chest Institute, University of Delhi, Delhi, India.
authors.forename: T D
authors.initials: TD
authors.lastname: Singh
authors.forename: K
authors.initials: K
authors.lastname: Patial
authors.forename: V K
authors.initials: VK
authors.lastname: Vijayan
authors.forename: K
authors.initials: K
authors.lastname: Ravi
mesh_terms: D000328:Adult; D000975:Antioxidants / Q000627:therapeutic use; D045422:Continuous Positive Airway Pressure / Q000379:methods; D005500:Follow-Up Studies; D005978:Glutathione / Q000097:blood; D006801:Humans; D015227:Lipid Peroxidation; D008297:Male; D018384:Oxidative Stress / Q000502:physiology*; D017286:Polysomnography; D011379:Prognosis; D012890:Sleep / Q000502:physiology; D020181:Sleep Apnea, Obstructive / Q000097:blood* / Q000503:physiopathology / Q000628:therapy
chemical_list: D000975:Antioxidants; D005978:Glutathione